An Open-label, Single-center, Phase 1/ 2 Study of Chemoradiotherapy and AT-101 in Patients With Locally Advanced Esophageal or Gastroesophageal Junction Cancer
Clinical trial NCT00561197 · TERMINATED
Trial details
- NCT number
- NCT00561197
- Sponsor
- Ascenta Therapeutics
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-08-01
- Primary completion
- 2010-09-01
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.